Coronavirus pandemic has killed over 4.7 lakh people across the globe. In India, the death toll is over 13,000. The good news is that DGCI has given nod to 3 companies to roll out their COVID-19 treatment medicine in India. These companies are -- Cipla, Glenmark and Hetero. And the three medicines are called Cipremi, FabiFlu and Covifor.
The three have reportedly shown good results so far and will be now slowly put into use under strict medical observation.
Here is everything we know about these drugs.